[Relationship between expression of lung resistance protein gene and clinical pathophysiological characteristics of lung cancer].
To study the relationship between lung resistance protein gene (LRP) expression and clinical pathophysiological characteristics of lung cancer. Expression of LRP gene was determined in 49 lung cancer samples and 41 corresponding paracancerous tissues by RT-PCR. LRP was expressed in lung cancers and corresponding paracancerous tissues. The positive expression rate was 63. 3%( 31/ 49) in cancer tissues and 21. 9% ( 9/ 41) in corresponding paracancerous tissues respectively ( P< 0. 01) . The positive rate in NSCLC ( 29/ 41, 70. 7%)was significantly higher than that in SCLC ( 2/ 8, 25%) ( P < 0. 05) , and the positive rate in adenocarcinoma ( 11/ 12, 91. 7%) was also remarkably higher than that in squamous cell carcinoma ( 11/ 22, 50%) ( P < 0. 05) . In addition, LRP expression in the smokers ( 26/ 35, 74. 3%) was significantly higher than that in the non-smokers ( 5/ 14, 35. 7%) ( P< 0. 05) . The expression of LRP may be related to drug resistance of lung cancer, and smoking may increase LRP gene expression.